AccuRad

What AccuRad does

AccuRad (西安盈谷网络科技有限公司 / Xi'an AccuRad Network & Technology Co. Ltd.) is a Xi'an-based medical imaging technology company founded in 2001 that operates 医真云 (YiZhen Cloud), a cloud-native SaaS platform serving medical institutions across China. The platform is built on the company's proprietary @iMAGES cloud image processing engine, NPE engine, and AMOL connection technology, delivering workstation-grade 2D/3D imaging, AI-assisted diagnosis across more than 240 NMPA-certified applications, regional medical alliance collaboration, and clinical big data analytics. AccuRad reports that 2,700+ medical institutions are connected to the platform, with cumulative online consultations exceeding 600 million as of June 2026 and a peak of 630,000 consultations per day.

The company generates revenue primarily through annual subscription SaaS fees from hospitals, medical chains, government health commissions, and medical alliances, supplemented by usage-based charges for premium AI diagnostic services and one-time licensing plus maintenance contracts for private/hybrid cloud deployments (the 医真超云 Max series). Distribution occurs through a direct enterprise field sales organization supplemented by strategic channel partnerships with China Telecom, China Unicom, China Mobile, Huawei, and Tencent Cloud. The platform has obtained CFDA/NMPA certifications since 2005, ISO 27001 data center certification, and Kylin OS NeoCertify compatibility, supporting both regulatory compliance and China's independent controllable IT requirements.

AccuRad's strategic focus is on full-stack medical technology SaaS combining imaging, AI, and clinical collaboration, with recent emphasis on large language model integration (DeepSeek partnership, thousands of institutions simultaneously connected) and intelligent agent deployment (40+ YiAgents). Key named customers include Jiaxing First Hospital, Xinjiang Autonomous Region People's Hospital, Wuxi People's Hospital, Jining Regional Imaging Collaboration Platform, Changsha Regional Medical Collaboration Platform, and Meinian Health. Strategic partnerships with Siemens Healthineers (announced April 2024) and Huawei anchor the technology and go-to-market stack.

Name

AccuRad

Legal name

西安盈谷网络科技有限公司

Website

https://accurad.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

101–250 employees

Short description

AccuRad operates 医真云 (YiZhen Cloud), a cloud-native medical imaging and AI SaaS platform serving 2,700+ hospitals, medical chains, and government health alliances across China with workstation-grade imaging, AI-assisted diagnosis, and clinical collaboration tools.

Ownership category

akta.pro rank

Product category

Medical Imaging SaaS

NAICS

Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Picture Archiving & Communication Systems (PACS) (HLACALAA)

akta.pro secondary industries

Industry/Vertical Cloud Platforms (e.g., Gov/Healthcare/Financial Cloud Regions) (HDABAAAL), Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic) (HLACALAD)

Keywords

• Medical imaging cloud
• AI diagnostics platform
• Medical SaaS
• Clinical imaging collaboration
• Radiology informatics

Headquarters

HQ city

Xian Shi

HQ country

China

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

1. Medical Cloud SaaS Subscription Services: AccuRad generates primary revenue through subscription-based SaaS cloud services provided to medical institutions, medical chains, government health commissions, and healthcare groups. Services are delivered via the 医真云 platform under 'Software as a Service' and 'Access as Service' models, with revenue recurring annually per institution or network.
2. Usage-based Medical Technology Services: Platform charges based on usage volume of medical technology services, with per-examination or per-consultation fees for certain AI diagnostic services and high-computation medical imaging processing.
3. Private/Hybrid Cloud Deployment (医真超云): Enterprise private cloud or hybrid cloud deployment solutions (医真超云 Max series) sold as one-time infrastructure projects or annual maintenance contracts to large hospital groups and government health commissions requiring on-premise deployment.
4. AI Application Store / Add-on AI Services: Revenue from NMPA-certified AI diagnostic applications (over 240 certified AI tools) available through the 医真AI+ open platform. Premium AI features and third-party AI application access generate incremental usage-based or subscription fees.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels4 records

Core offering

AccuRad provides a cloud-native medical imaging and full medical technology SaaS platform (YiZhen Cloud / 医真云) serving hospitals, medical chains, and government health commissions. The platform delivers 20+ services including clinical imaging collaboration, AI-assisted diagnostics across 240+ NMPA-certified applications, regional medical alliance platforms, and remote healthcare. It is powered by proprietary @iMAGES cloud image processing engine, NPE engine, and AMOL connection technology, enabling workstation-grade image processing on any device without expensive on-premise PACS infrastructure.

Product overview

AccuRad (西安盈谷网络科技有限公司) offers a cloud-native medical imaging SaaS platform centered on 医真云, supplemented by the @iMAGES processing engine, 医真超云 storage-computing integrated machines (MaxCube, Max2000, Max200), 医真大脑 AI platform (240+ AI tools), YiAgents intelligent agent system, and 智能3D电子胶片. The platform integrates DeepSeek LLM for enhanced AI capabilities and serves medical institutions across clinical imaging, collaboration, research, and regional healthcare networks.

Differentiator

Problem solved

Functional benefit

Brands

• 医真云 (YiZhen Cloud): Cloud-based medical imaging and AI SaaS platform serving medical institutions with imaging data services, clinical collaboration, and AI diagnostics
• 医真大脑 (YiZhen Brain)
• 医真健康 (YiZhen Health)
• 医真眼 (YiZhen Eye)
• iMAGES/@iMAGES
• 医真超云 (YiZhen Super Cloud)
• YiAgents
• 沃·医真 (Wo YiZhen)

Products and services

• YiZhen Cloud (医真云) Cloud-native, full-stack SaaS platform providing 20+ types of full-matrix medical technology services including clinical image collaboration, precise full medical technology work and collaboration system, clinical big data platform, medical alliance/regional collaboration platform, remote healthcare, independent imaging center cloud platform, expert services, and doctor social networking. Serves hospitals, medical chains, and government health commissions across China.
• @iMAGES Cloud Image Processing Engine World's first cloud-based medical image processing and analysis engine. Supports full-resolution medical image visualization, processing, 3D reconstruction and analysis in real-time. Delivers 95%+ of original advanced workstation functionality with EB-level image storage management. CFDA certified for medical device compliance.
• YiZhen Super Cloud (医真超云) - Max Series Private/hybrid cloud deployment solution (MaxCube, Max2000, Max200 series) combining Huawei's hardware infrastructure with AccuRad's software platform. Sold as one-time infrastructure projects or annual maintenance contracts to large hospital groups and government health commissions requiring on-premise deployment with super convergence big data architecture.
• YiZhen Cloud HD (医真云HD) High-definition version of the YiZhen Cloud platform optimized for Huawei tablet and large-screen devices, providing medical imaging and AI diagnostic services on enterprise tablet form factors.
• Smart 3D Electronic Film (智能3D电子胶片) Intelligent 3D electronic medical imaging film enabling patients and doctors to view medical images anytime, anywhere via mobile scanning. 3D visualization replaces traditional physical films, providing enhanced clinical review capabilities.
• Full AI Ecosystem with YiAgents (医真智能全智能人工智能生态) Comprehensive AI ecosystem integrating general large language models (DeepSeek), multimodal models, and deep learning as foundation. Includes 40+ YiAgents intelligent agents covering appointment booking, technician operations, intelligent diagnosis, MDT consultations, and patient health services, plus 240+ NMPA-certified AI applications (Class II and III). First disease spectrum-level full intelligent AI architecture covering 80% of major and common diseases in China.

Quantifiable outcome

• Lung nodule AI detection reduces screening time from 10+ minutes to 5-17 seconds, with detection rate above 95%
• +5 more outcomes

Named customers6 records

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability8 records

Feature8 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• Siemens Healthineers (西门子医疗)coreStrategic or Co-development Partner · 12 April 2024Strategic partnership announced April 12, 2024 to jointly create a 'full intelligent' AI cloud ecosystem. The partnership integrates Siemens Healthineers' imaging equipment with AccuRad's cloud platform and AI capabilities, targeting the Chinese medical imaging market with combined solutions for hospitals and healthcare systems.
• China Telecom Shaanxi (中国电信陕西分公司)coreChannel Partner/ Reseller/ Distributor · 22 March 2024Strategic cooperation agreement for deploying medical cloud services in Shaanxi province. China Telecom provides network infrastructure and market access through its telecom operator channels, while AccuRad provides the 医真云 platform and AI capabilities for healthcare institutions.
• Huawei (医真超云存算一体机 Joint Launch)coreTechnology or Integration · 15 March 2024Co-launched '医真超云存算一体机' - a full-stack trust-based, high-performance computing and hyper-converged architecture intelligent full medical technology system, combining Huawei's hardware infrastructure with AccuRad's software platform.
• Huawei (华为)coreTechnology or Integration · 23 October 2018Comprehensive strategic partnership for medical cloud and AI. Includes joint healthcare solutions (华为&盈谷智慧医疗联合解决方案), Huawei Cloud marketplace listing, Kunpeng ecosystem certification, and co-development of '医真超云存算一体机' (super cloud storage-computing integrated machine) with full-stack trust-based architecture. AccuRad is a founding member of Huawei Cloud Medical Health Kunpeng Industry Alliance.
• Guoyao Kunming (国药昆明)minorChannel Partner/ Reseller/ Distributor · 1 August 2018Strategic cooperation to deploy 医真云 in Yunnan province's health commission and medical institutions. Guoyao Kunming leverages its healthcare distribution network and government relationships in Yunnan.
• New H3C (新华三)minorStrategic or Co-development Partner · 20 June 2018Strategic partnership to jointly build a new medical ecosystem. New H3C integrates its networking and IT infrastructure with AccuRad's medical cloud platform to offer comprehensive smart medical solutions.
• Chinasoft International (中软国际)minorImplementation/ SI/ Consulting Partner · 31 August 2017Strategic cooperation to build next-generation internet+ medical imaging service application platform. Chinasoft International provides technology integration, development, and training certification for the 医真 platform.
• Meinian Health (美年大健康)coreStrategic or Co-development Partner · 5 August 2017Strategic cooperation to deploy medical imaging cloud services across Meinian's chain of health examination centers. Meinian integrates 医真云 for imaging data platform, ECG platform, and structured data exchange across its national health screening network.
• Xidian University (西安电子科技大学)minorStrategic or Co-development Partner · 5 August 2017Joint establishment of a medical AI joint laboratory with Xidian University's School of Electronic Engineering and Intel China, for collaborative research and development of medical AI technologies.
• China Unicom - Multiple Branches (中国联通)coreChannel Partner/ Reseller/ DistributorLong-standing partnership with China Unicom's Jiangsu, Henan, and Guangdong branches to deploy co-branded '沃·医真云' medical cloud services. Unicom leverages its telecom network infrastructure and enterprise sales channels to distribute medical cloud services to hospitals and government healthcare customers across provinces.
• China Mobile Guangdong (中国移动广东河源分公司)minorChannel Partner/ Reseller/ DistributorPartnership with China Mobile Guangdong to deploy 3D electronic medical films and cloud imaging services at hospitals including Guangdong Provincial People's Hospital Heyuan Hospital.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• United Imaging Healthcare (联影医疗): China's leading integrated medical imaging equipment vendor with a growing uAI software platform covering imaging, AI diagnostics, and hospital informatics. Direct competitor to AccuRad in Chinese cloud medical imaging SaaS, especially for hospital and medical alliance segments.
• Carestream Health: Vendor of medical imaging IT (Vue PACS, Vue Reporting) and enterprise imaging workflows. Directly comparable on cloud-enabled PACS and multi-site imaging collaboration offerings targeted at hospitals and IDNs.
• Shukun Technology (数坤科技): Chinese medical imaging AI company focused on cardiac and vascular imaging AI, integrated with hospital PACS/IT systems. Comparable to AccuRad in offering AI-assisted diagnostic overlays and SaaS distribution into Chinese hospital networks.
• Aidoc: Israel-based medical imaging AI platform with FDA-cleared AI algorithms for CT and radiology triage, sold to hospital systems. Direct comparable on AI-augmented imaging workflow overlay, with similar go-to-market into hospital radiology departments.
• Yitu Medical (依图科技): Yitu's medical imaging AI business (including care.ai) competes in chest, cardiac, and CT triage AI used by Chinese hospitals. Comparable product surface (medical imaging AI + clinical workflow) and target customer set to AccuRad's hospital SaaS platform.
• InferVision (推想科技): Beijing-headquartered AI company specializing in medical imaging AI for chest CT, DR, and CT workflows, deployed across hundreds of Chinese hospitals. Competes with AccuRad's AI diagnostic capabilities and lung nodule detection on imaging SaaS platforms.

Broad incumbents

• Philips Healthcare: Global incumbent offering IntelliSpace PACS, advanced visualization, and AI-enabled diagnostic workflows. Comparable to AccuRad in enterprise imaging informatics and AI-augmented diagnostic platforms globally and in China.
• Ping An Healthcare and Technology (平安好医生): Large Chinese digital health platform with imaging AI and telemedicine offerings as part of a broader healthcare ecosystem. Competes at the regional healthcare collaboration and Internet hospital layer with substantially greater capital base than AccuRad.
• GE HealthCare: Global incumbent offering imaging modalities, Centricity PACS, and Edison AI platform across Chinese hospitals. Competes broadly with AccuRad on hospital imaging IT and AI diagnostics through a global portfolio with deep China presence.
• Siemens Healthineers: Global incumbent in medical imaging equipment, PACS, and advanced visualization (syngo.via). Already a strategic partner to AccuRad for 'Full Intelligence' cloud+AI; competes on higher-end on-premise and enterprise imaging portfolios while partnering on AI cloud ecosystem.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds3 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AccuRad